Federal Register: Medications for the Treatment of Opioid Use Disorder – Final Rule

The new final rule also includes the following additional provisions:

  • Allows the use of telehealth to initiate treatment for an OUD and to reduce transportation barriers; for treatment with methadone, audio-visual telehealth is allowed, and for treatment using buprenorphine, audio-only technologies are permitted
  • Allows nurse practitioners and physician assistants to order medications in opioid treatment programs, where state laws permit such a practice
  • Eliminates “stringent admission criteria,” which previously restricted eligibility for treatment to those with at least a 1-year history of addiction
  • Increases access to “interim treatment” by enabling patients to start medications while waiting for additional services to become available
Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials

or    

Forgot your details?

Create Account